GlassScriptPhysician profile
Susan L Edwards
NPI 1992730139
$4,244.69
in general payments reported to CMS, 2019-2025
44 companies · $23.65 in 2025
The $23.65 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $581 · 2020: $769 · 2021: $664 · 2022: $882 · 2023: $725 · 2024: $600 · 2025: $23.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,347.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $423.41 | 2020-2024 | Ubrelvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $416.88 | 2019-2024 | Jardiance, Synjardy |
| Amgen INC. | $282.16 | 2019-2024 | Repatha, Otezla, Evenity |
| Amarin Pharma, INC. | $274.29 | 2019-2021 | |
| Lilly USA, LLC | $265.12 | 2019-2024 | Mounjaro, Trulicity, Jardiance |
| Novo Nordisk INC | $228.57 | 2019-2021 | |
| Glaxosmithkline, LLC. | $218.69 | 2019-2024 | Shingrix, Arexvy, Bexsero |
| Gilead Sciences, INC. | $180.26 | 2019-2023 | |
| Pfizer INC. | $159.71 | 2019-2023 | |
| Allergan, INC. | $127.24 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $120.62 | 2020-2023 | |
| Abbott Laboratories | $117.91 | 2022-2025 | Freestyle Libre 2, Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $115.54 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $108.25 | 2019-2022 | |
| Viiv Healthcare Company | $104.24 | 2023-2024 | Apretude |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.